Market Snapshot

Market Overview

Market Overview

Global Eubiotics Market size exceeded USD 3.9 Billion, globally in 2019 and is estimated to grow at over 8.5% CAGR between 2020 and 2026. Stringent regulations pertaining to feed quality along with improved spending on microbial technology will boost the product demand during the forecast timeframe.

Growing awareness pertaining to benefits of animal derived end products accompanied by favorable government initiatives to improve feed quality is likely to boost the eubiotics market expansion. These products are widely used in supplementing diets of fairy & beef cows, swine, ruminants, and aquaculture industry. Eubiotics solutions aid in boosting the immune system against bacterial or viral infections along with improving the digestive efficacy.

Increasing meat consumption due to large scale meat production along with easy availability of meat products likely to stimulate product demand. Global meat market was over USD 40 billion in 2018 owing to rising disposable income and changing dietary patterns. Global meat production was nearly 323 million tonnes in 2017 and is anticipated to cross 450 million tonnes by 2030. Surge in disposable incomes along with strong growth in the processed food & beverage industry will support the eubiotics market demand over the projected timeframe.

Manufacturers are investing in research & new product development in order to produce targeted solutions, gain brand recognition, and boost the eubiotics market share. Factors such as advancements in molecular biology and gene sequencing have generated new growth opportunities for the industry participants. Additionally, companies collaborate or partner for technology developments and product launches and form agreements or distributor agreements. However, the outbreak of COVID-19 has affected the industry in terms of supply chain disruptions and reduced demand for meat products.

Stringent regulatory guidelines by FDA and EU Commission towards ban of antibiotics growth promoter (AGP) due to bioaccumulation of antibiotics in animal’s gastrointestinal tract and meat products which results in adverse effects on human & animal health has led to rising need for natural growth promoters. Products such as essential oils, organic acids, prebiotics and probiotics are potential replacements for AGP’s and provide addition benefits, thereby supporting the eubiotics market advancement.

Prebiotics is projected to be the fastest growing segment witnessing CAGR over 10% from 2020 to 2026. Inulin and mannan-oligosaccharides (MOS) are the majorly used prebiotics for the animal feed industry. Prebiotics dietary fibres are mainly fed to animals to improve secretion of digestive enzymes to enhance digestive metabolism supported by increasing immune response to protect them from environmental stress.

Prebiotics reduce the prevalence of pathogens in the food chain by maintaining the digestive health. Livestock manufacturers adoption of natural growth promoters and nutrients to increase performance, feed efficiency and weight gain should fuel the eubiotics market growth.

Exogenous enzymes dominated the global eubiotics market revenue share with over 35% in 2019. Exogenous enzymes such a protease, amylase, and phytase are widely used in supplementing feed solutions. These enzymes help in breaking down of starch, protein, and beta g feed products which increase nutrient absorption and digestive efficacy. Furthermore, rising demand for high quality milk, eggs, and meat is likely to stimulate the demand of exogenous enzymes solutions.

Eubiotics products for gut health contribute for nearly 40% of the global eubiotics demand. Gut infections may lead to low efficiency, low yield along with additional cost in treatments and trade losses which has resulted in need for eubiotics product to maintain gut integrity and functionality. Rising influence towards animal health and nutrition to prevent further losses should contribute towards the eubiotics market.

Uncover key market trends, investment insights, and global economic impacts driving this industry's growth
Download Free Overview Report

Porter 5

Market Segmentation

Company Performance

Financial values in the chart are available after report is purchased.

Our Company Coverage

Our comprehensive company performance report offers a detailed analysis of critical factors for our clients' industry insights. It covers key financial metrics, such as revenue, profit, and profit margin, providing a clear financial overview. We also assess the company's structure by identifying key subsidiaries and top industry competitors, conducting a thorough SWOT analysis to reveal strengths, weaknesses, opportunities, and threats. The report includes an in-depth income statement for financial assessment and a credit analysis for evaluating creditworthiness. Industry-specific data and benchmarks enable clients to compare performance, providing actionable insights for strategic decisions and competitive advantages.

Corporate Information

Main activities
Number of employees
Key executives
Company Description
Similar companies
Ownership details
Financial Performance Charts
Top Competitors
Similar companies
Ownership details
Financial Performance Charts
Top Competitors

Corporate Information

Income statement
Credit analysis
Credit analysis
Benchmark score

Depending on the size and type of the organisation we may also provide:

News: Business/financial results, investments and deals
Reports: Annual reports, broker reports
M&A: Information on past deals, deal intents
Discover the industry's latest trends, global economic factors, and impactful investments driving its expansion.
Download Free Sample
Download Free Sample

Table of Contents

Table of Contents

1. Research Methodology and Scope

2. Executive Summary

3. Impact of COVID-19 on Eubiotics Market

4. Market Dynamics

        4.1 Drivers

        4.2 Restraints

5. Competitive Landscape

        5.1 Key Strategies Adopted by Major Companies

6. Eubiotics Market Segmentation by Type

        6.1 Probiotics

        6.2 Prebiotics

        6.3 Organic Acids

        6.4 Others

7. Eubiotics Market Segmentation by Applications

        7.1 Gut Health

        7.2 Immunity

8. Eubiotics Market Segmentation by Distribution Channel

        8.1 Swine

        8.2 Poultry

        8.3 Aquaculture

        8.3 Others

9. Eubiotics Market by Geography

        9.1 North America

                 9.1.1 United States

                 9.1.2 Canada

                 9.1.3 Mexico

        9.2 Europe

                 9.2.1 United Kingdom

                 9.2.2 France

                 9.2.3 Italy

                 9.2.4 Germany

                 9.2.5 Rest of Europe

        9.3 Asia-Pacific

                 9.3.1 Singapore

                 9.3.2 India

                 9.3.3 Japan

                 9.3.4 Australia

                 9.3.5 Rest of Asia-Pacific

        9.4 South America

                 9.4.1 Brazil

                 9.4.2 Rest of South America

        9.5 Middle East and Africa

10. Eubiotics Market Segmentation by Form

        10.1 Solid or Dry Form

        10.2 Liquid Form

11. Eubiotics Market Segmentation by End User

        11.1 Industrial Livestock

        11.2 Domesticated Animals

12. Eubiotics Market Segmentation by Packaging Type

        12.1 Stand-up Pouches

        12.2 Bulk Packaging

13. Eubiotics Company Profiles

        13.1 Anpario plc

        13.2 Archer Daniels Midland

        13.3 BioGaia AB

        13.4 BASF

        13.5 Bluestar Adisseo

        13.6 Chr. Hansen Holding

        13.7 DuPont de Nemours

        13.8 Novozymes A/S

        13.9 Yara International

        13.10 ADDCON GmbH

14. Appendix

Research Methodology

Porter Five Forces Analysis

Major Players

No items found.